Virogenics

Pharmingen, located in San Diego, CA, offers a wide range of solutions for healthcare facilities, including ambulatory surgery center solutions, diagnostic accuracy tools, medication management solutions, and patient safety initiatives. With a focus on hazardous drug safety, integrated diagnostic solutions, and targeted temperature management, Pharmingen aims to enhance the efficiency and effectiveness of medical practices. Specializing in areas such as sepsis management, vascular access, and surgical solutions, Pharmingen provides innovative products and services to support healthcare professionals in delivering high-quality patient care. With a commitment to advancing the world of health, Pharmingen continues to empower discovery and improve health outcomes through its comprehensive range of medical solutions. Generated from the website

Sequenom provides genetic analysis products that translate genomic science into solutions for non-invasive prenatal testing, biomedical research, molecular medicine and agricultural applications. Its proprietary MassARRAY system is a DNA analysis platform that measures the amount of genetic target material and variations therein. The system is able to deliver specific data from biological samples and from trace amounts of genetic target material. The company has licensed intellectual property rights for the development and commercialization of non-invasive prenatal genetic tests for use with the MassARRAY system and other platforms. Sequenom has headquarters in San Diego and offices in Newton, Mass, Germany, England and Australia.

Biomatrica, based in San Diego, CA, is a subsidiary of Exact Sciences Corporation, specializing in innovative solutions for molecular diagnostics and sample preservation. Their LBgard Blood Tubes offer advanced applications for use in various studies and evaluations. With a focus on health equity and cutting-edge science, Biomatrica collaborates with experts in the field to develop products like the Oncotype DX tests and Cologuard for early cancer detection. Their commitment to research and clinical studies underscores their dedication to delivering confidence in healthcare outcomes.Generated from the website